These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 14534310)
1. Structures of gamma-aminobutyric acid (GABA) aminotransferase, a pyridoxal 5'-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with gamma-ethynyl-GABA and with the antiepilepsy drug vigabatrin. Storici P; De Biase D; Bossa F; Bruno S; Mozzarelli A; Peneff C; Silverman RB; Schirmer T J Biol Chem; 2004 Jan; 279(1):363-73. PubMed ID: 14534310 [TBL] [Abstract][Full Text] [Related]
2. Design of a conformationally restricted analogue of the antiepilepsy drug Vigabatrin that directs its mechanism of inactivation of gamma-aminobutyric acid aminotransferase. Choi S; Storici P; Schirmer T; Silverman RB J Am Chem Soc; 2002 Feb; 124(8):1620-4. PubMed ID: 11853435 [TBL] [Abstract][Full Text] [Related]
3. Crystal structure of GABA-aminotransferase, a target for antiepileptic drug therapy. Storici P; Capitani G; De Biase D; Moser M; John RA; Jansonius JN; Schirmer T Biochemistry; 1999 Jul; 38(27):8628-34. PubMed ID: 10393538 [TBL] [Abstract][Full Text] [Related]
4. Probing the steric requirements of the γ-aminobutyric acid aminotransferase active site with fluorinated analogues of vigabatrin. Juncosa JI; Groves AP; Xia G; Silverman RB Bioorg Med Chem; 2013 Feb; 21(4):903-11. PubMed ID: 23306054 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of cyclopropane isosteres of the antiepilepsy drug vigabatrin and evaluation of their inhibition of GABA aminotransferase. Wang Z; Silverman RB J Enzyme Inhib Med Chem; 2004 Aug; 19(4):293-301. PubMed ID: 15558944 [TBL] [Abstract][Full Text] [Related]
6. Active site model for gamma-aminobutyrate aminotransferase explains substrate specificity and inhibitor reactivities. Toney MD; Pascarella S; De Biase D Protein Sci; 1995 Nov; 4(11):2366-74. PubMed ID: 8563634 [TBL] [Abstract][Full Text] [Related]
7. Selective Targeting by a Mechanism-Based Inactivator against Pyridoxal 5'-Phosphate-Dependent Enzymes: Mechanisms of Inactivation and Alternative Turnover. Mascarenhas R; Le HV; Clevenger KD; Lehrer HJ; Ringe D; Kelleher NL; Silverman RB; Liu D Biochemistry; 2017 Sep; 56(37):4951-4961. PubMed ID: 28816437 [TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics simulations of apo, holo, and inactivator bound GABA-at reveal the role of active site residues in PLP dependent enzymes. Gökcan H; Monard G; Sungur Konuklar FA Proteins; 2016 Jul; 84(7):875-91. PubMed ID: 26800298 [TBL] [Abstract][Full Text] [Related]
9. Theoretical study on HF elimination and aromatization mechanisms: a case of pyridoxal 5' phosphate-dependent enzyme. Gökcan H; Konuklar FA J Org Chem; 2012 Jul; 77(13):5533-43. PubMed ID: 22646918 [TBL] [Abstract][Full Text] [Related]
10. Crystal structure of γ-aminobutyrate aminotransferase in complex with a PLP-GABA adduct from Corynebacterium glutamicum. Hong J; Kim KJ Biochem Biophys Res Commun; 2019 Jun; 514(3):601-606. PubMed ID: 31072617 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of inactivation of γ-aminobutyric acid aminotransferase by (1S,3S)-3-amino-4-difluoromethylene-1-cyclopentanoic acid (CPP-115). Lee H; Doud EH; Wu R; Sanishvili R; Juncosa JI; Liu D; Kelleher NL; Silverman RB J Am Chem Soc; 2015 Feb; 137(7):2628-40. PubMed ID: 25616005 [TBL] [Abstract][Full Text] [Related]